2 options
COVID-19 and beyond : oversight of the FDA's foreign drug manufacturing inspection process : hearing before the Committee on Finance, United States Senate, One Hundred Sixteenth Congress, second session, June 2, 2020.
- Format:
- Book
- Government document
- Author/Creator:
- United States. Congress. Senate. Committee on Finance, author.
- Series:
- United States. Congress. Senate. S. hrg. ; 116-490.
- S. hrg. ; 116-490
- Language:
- English
- Subjects (All):
- United States. Food and Drug Administration.
- United States.
- Drug control--United States.
- Drug control.
- COVID-19 (Disease)--United States.
- COVID-19 (Disease).
- COVID-19 Pandemic, 2020-2023--United States.
- COVID-19 Pandemic, 2020-2023.
- Genre:
- Legislative hearings
- Legislative hearings.
- Physical Description:
- 1 online resource (iv, 227 pages) : illustrations.
- Other Title:
- Oversight of the FDA's foreign drug manufacturing inspection process
- Place of Publication:
- Washington : U.S. Government Publishing Office, 2021.
- Notes:
- Includes bibliographical references.
- Date of hearing: 2020-06-02.
- Description based on online resource; title from PDF title page (govinfo, viewed Oct. 9, 2021).
- Other Format:
- Print version: United States. Congress. Senate. Committee on Finance. COVID-19 and beyond
- OCLC:
- 1274519283
- Publisher Number:
- 45-640 (GPO jacket number)
The Penn Libraries is committed to describing library materials using current, accurate, and responsible language. If you discover outdated or inaccurate language, please fill out this feedback form to report it and suggest alternative language.